Chan TA, Weingart JD, Parisi M, Hughes MA, Olivi A, Borzillary S, Alahakone D, Detorie NA, Wharam MD, Kleinberg L.. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.. Int J Radiat Oncol Biol Phys Jul 2005; 62(4) :1133-9
Chan, TA. Nonsteroidal anti-inflammatory drugs, apoptosis, and colon-cancer chemoprevention.. Lancet Oncology Mar 2002; 3(3) :166-74
Chan TA, Wang Z, Dang LH, Vogelstein B, Kinzler KW. . Targeted inactivation of CTNNB1 reveals unexpected effects of beta-catenin mutation.. Proc Natl Acad Sci U S A. Jun 11, 2002; 99(12) :8265-70
He TC, Chan TA, Vogelstein B, Kinzler KW.. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs.. Cell Oct 29, 1999; 99(3) :335-45
Chan TA, Hermeking H, Lengauer C, Kinzler KW, Vogelstein B.. 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage.. Nature Oct 7, 1999; 401(6753) :616-20
Zhou X, Suzuki H, Lei J, Cole K, Yin J, Suzuki V, Abraham JM, Shimada Y, Imamura M, Chan T, Hannon GJ, Meltzer SJ.. Growth suppression of esophageal cancer cells by p16INK4 and p15INK4B in vitro. Cancer J Sci Am. 1996 Jul-Aug;2(4):221-4. July 1, 1996; 2(4) :197-9
Suzuki H, Zhou X, Yin J, Lei J, Jiang HY, Suzuki Y, Chan T, Hannon GJ, Mergner WJ, Abraham JM, et al.. Intragenic mutations of CDKN2B and CDKN2A in primary human esophageal cancers.. Hum Mol Genet. October 1, 1995; 4(10) :1883-7
Return to Timothy A. Chan, MD, PhD Main Page.
